Method and apparatus for generating nitric oxide for medical use
A method and system for generating and delivering nitric oxide directly to a patient. A reaction chamber is provided that is located at or in close proximity to the patient and reactants within the reaction chamber react together to produce a predetermined amount of nitric oxide. The reaction is controlled by metering at least one of the reactants into the reaction chamber to generate a predetermined quantity of nitric oxide as required by the patient. The reactants can include a nitrite salt, such as sodium nitrite, and a reductant such as ascorbic acid, maleic acid or a mixture thereof. By generating and delivering the nitric oxide directly to the patient in close proximity thereto, the formation of NO 2 is minimized. One or both of the reactants may be in liquid form.
1. A method of controlled delivery of nitric oxide (NO) gas to the lung of a human patient in need thereof by inhalation comprising:
delivering aqueous droplets comprising dissolved nitrite salt compound via pulses from a first liquid dispenser to a location on a rotatable reaction surface at a first position in a reaction chamber in fluid communication with the lung by inhalation of the human patient;
rotating the rotatable reaction surface to a second position;
delivering droplets comprising a liquid reductant via pulses from a second liquid dispenser to substantially the same location on the rotatable reaction surface in the reaction chamber as the aqueous droplets comprising dissolved nitrite salt compound;
generating NO gas by reacting the dissolved nitrite salt with the reductant in the reaction chamber; and
delivering an amount of the generated NO to the lung of the human patient;
wherein the reductant comprises ascorbic acid and maleic acid at a 1:1 molar ratio.
2. The method of controlled delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 1 , wherein generating NO comprises continuous reaction of the nitrite salt and the reductant.
3. The method of controlled delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 1 , wherein the NO is delivered at a concentration in a range of 5 ppm to 80 ppm.
4. The method of controlled delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 1 , wherein the nitrite salt compound is sodium nitrite.
5. The method of controlled delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 1 , wherein the droplets are delivered at a rate based upon an alveolar volume of the patient and a concentration of NO to be inhaled by the patient.
6. The method of controlled delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 1 , further comprising the step of controlling the amount of NO delivered to the lung of the patient by controlling the frequency at which the aqueous nitrite salt compound droplets are contacted with the liquid reductant.
7. A device for controlled intermittent or continuous delivery of nitric oxide (NO) gas to the lung of a human patient in need thereof by inhalation, the device comprising:
a reaction chamber comprising a rotatable reaction surface in fluid communication with the lung by inhalation with the human patient;
a first controllable liquid dispensing system adapted to spray aqueous droplets comprising dissolved nitrite salt compound to a location in the reaction chamber at a pulsed rate into contact with a liquid reductant;
a second controllable liquid dispensing system adapted to spray at a pulsed rate the liquid reductant at substantially the same location on the rotatable reaction surface in the reaction chamber as the aqueous droplets comprising dissolved nitrite salt compound; and
an outlet for discharging NO gas from the reaction chamber for delivery to the patient;
wherein delivery of NO gas to the lung is controlled by controlling the frequency at which the aqueous nitrite salt compound droplets are contacted with the liquid reductant, and
wherein the reductant comprises ascorbic acid and maleic acid at a 1:1 molar ratio.
8. The device for controlled intermittent or continuous delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 7 , wherein the first controllable liquid dispensing system is comprised of at least one micropump.
9. The device for controlled intermittent or continuous delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 8 , wherein the second controllable liquid dispensing system is comprised of at least one micropump.
10. The device for controlled intermittent or continuous delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 7 , wherein the droplets have a volume in the range of 10 picoliters to 100 picoliters.
11. The device for controlled intermittent or continuous delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 7 , wherein the nitrite salt compound is sodium nitrite.
12. The device for controlled intermittent or continuous delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 7 , further comprising a ventilator adapted to provide inspiratory gas to the patient through the device for controlled delivery of NO.
13. The device for controlled intermittent or continuous delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 7 , further comprising an input device adapted to set the desired concentration of NO to be delivered to the patient, and a flow sensor adapted to determine the flow of gas provided by the ventilator, wherein the amount of NO delivered to the patient is based on the desired concentration entered into the input device.
14. A device for controlled intermittent or continuous delivery of nitric oxide (NO) gas to the lung of a human patient in need thereof by inhalation, the device comprising:
a reaction chamber comprising a rotatable reaction surface in fluid communication with the lung by inhalation with the patient;
a first controllable liquid dispensing system adapted to spray aqueous droplets comprising dissolved nitrite salt compound in the range of 10 picoliters to 100 picoliters at a pulsed rate into contact with a liquid reductant;
a second controllable liquid dispensing system adapted to spray at a pulsed rate the liquid reductant at substantially the same location on the rotatable reaction surface in the reaction chamber as the aqueous droplets comprising dissolved nitrite salt compound;
an outlet for discharging NO gas from the reaction chamber for delivery to the patient;
a ventilator in fluid communication with the outlet and adapted to provide inspiratory gas to the patient through the device for controlled delivery of NO gas;
wherein delivery of NO gas to the lung is controlled by controlling the frequency at which the aqueous nitrite salt compound droplets are contacted with the liquid reductant;
wherein the nitrite salt compound is sodium nitrite and the liquid reductant is ascorbic acid and maleic acid; and
wherein the ascorbic acid and maleic acid are at a 1:1 molar ratio.
15. The device for controlled intermittent or continuous delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 14 , wherein the first controllable liquid dispensing system is comprised of at least one micropump.
16. The device for controlled intermittent or continuous delivery of nitric oxide (NO) to the lung of a human patient in need thereof by inhalation according to claim 14 , wherein the second controllable liquid dispensing system is comprised of at least one micropump.